VHL was originally identified as a tumour suppressor gene in the hereditary VHL disease1 that develops a limited spectrum of tumours such as clear cell renal cell carcinoma (ccRCC), pheochromocytoma and hemangioblastoma2. This evidence concerns the gene VHL and nonpapillary renal cell carcinoma.